324 related articles for article (PubMed ID: 33408525)
1. The Dynamic Process and Its Dual Effects on Tumors of Therapy-Induced Senescence.
Liao C; Xiao Y; Liu L
Cancer Manag Res; 2020; 12():13553-13566. PubMed ID: 33408525
[TBL] [Abstract][Full Text] [Related]
2. Overcoming the senescence-associated secretory phenotype (SASP): a complex mechanism of resistance in the treatment of cancer.
Chambers CR; Ritchie S; Pereira BA; Timpson P
Mol Oncol; 2021 Dec; 15(12):3242-3255. PubMed ID: 34137158
[TBL] [Abstract][Full Text] [Related]
3. The Jekyll and Hyde of Cellular Senescence in Cancer.
Demirci D; Dayanc B; Mazi FA; Senturk S
Cells; 2021 Jan; 10(2):. PubMed ID: 33494247
[TBL] [Abstract][Full Text] [Related]
4. Senescent cells and SASP in cancer microenvironment: New approaches in cancer therapy.
Özdemir A; Şimay Demir YD; Yeşilyurt ZE; Ark M
Adv Protein Chem Struct Biol; 2023; 133():115-158. PubMed ID: 36707199
[TBL] [Abstract][Full Text] [Related]
5. Senescent Cells in Cancer Therapy: Friends or Foes?
Wang B; Kohli J; Demaria M
Trends Cancer; 2020 Oct; 6(10):838-857. PubMed ID: 32482536
[TBL] [Abstract][Full Text] [Related]
6. The role of cellular senescence and SASP in tumour microenvironment.
Takasugi M; Yoshida Y; Hara E; Ohtani N
FEBS J; 2023 Mar; 290(5):1348-1361. PubMed ID: 35106956
[TBL] [Abstract][Full Text] [Related]
7. Senescent cells in cancer therapy: why and how to remove them.
Zhang JW; Zhang D; Yu BP
Cancer Lett; 2021 Nov; 520():68-79. PubMed ID: 34237406
[TBL] [Abstract][Full Text] [Related]
8. Therapy-Induced Senescence: An "Old" Friend Becomes the Enemy.
Saleh T; Bloukh S; Carpenter VJ; Alwohoush E; Bakeer J; Darwish S; Azab B; Gewirtz DA
Cancers (Basel); 2020 Mar; 12(4):. PubMed ID: 32235364
[TBL] [Abstract][Full Text] [Related]
9. Cellular senescence: a double-edged sword in cancer therapy.
Xiao S; Qin D; Hou X; Tian L; Yu Y; Zhang R; Lyu H; Guo D; Chen XZ; Zhou C; Tang J
Front Oncol; 2023; 13():1189015. PubMed ID: 37771436
[TBL] [Abstract][Full Text] [Related]
10. Senescence of Tumor Cells in Anticancer Therapy-Beneficial and Detrimental Effects.
Piskorz WM; Cechowska-Pasko M
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232388
[TBL] [Abstract][Full Text] [Related]
11. Senotherapy, cancer, and aging.
Balducci L; Falandry C; Silvio Monfardini
J Geriatr Oncol; 2024 May; 15(4):101671. PubMed ID: 37977898
[TBL] [Abstract][Full Text] [Related]
12. Distinct mechanisms mediating therapy-induced cellular senescence in prostate cancer.
Kallenbach J; Atri Roozbahani G; Heidari Horestani M; Baniahmad A
Cell Biosci; 2022 Dec; 12(1):200. PubMed ID: 36522745
[TBL] [Abstract][Full Text] [Related]
13. Cancer Response to Therapy-Induced Senescence: A Matter of Dose and Timing.
Mongiardi MP; Pellegrini M; Pallini R; Levi A; Falchetti ML
Cancers (Basel); 2021 Jan; 13(3):. PubMed ID: 33513872
[TBL] [Abstract][Full Text] [Related]
14. Non-Cell Autonomous Effects of the Senescence-Associated Secretory Phenotype in Cancer Therapy.
Saleh T; Tyutynuk-Massey L; Cudjoe EK; Idowu MO; Landry JW; Gewirtz DA
Front Oncol; 2018; 8():164. PubMed ID: 29868482
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype.
Kumari R; Jat P
Front Cell Dev Biol; 2021; 9():645593. PubMed ID: 33855023
[TBL] [Abstract][Full Text] [Related]
16. Trabectedin modulates the senescence-associated secretory phenotype and promotes cell death in senescent tumor cells by targeting NF-κB.
Camorani S; Cerchia L; Fedele M; Erba E; D'Incalci M; Crescenzi E
Oncotarget; 2018 Apr; 9(28):19929-19944. PubMed ID: 29731994
[TBL] [Abstract][Full Text] [Related]
17. Keeping the senescence secretome under control: Molecular reins on the senescence-associated secretory phenotype.
Malaquin N; Martinez A; Rodier F
Exp Gerontol; 2016 Sep; 82():39-49. PubMed ID: 27235851
[TBL] [Abstract][Full Text] [Related]
18. Senescence-Induced Chemoresistance in Triple Negative Breast Cancer and Evolution-Based Treatment Strategies.
Chakrabarty A; Chakraborty S; Bhattacharya R; Chowdhury G
Front Oncol; 2021; 11():674354. PubMed ID: 34249714
[TBL] [Abstract][Full Text] [Related]
19. The Premature Senescence in Breast Cancer Treatment Strategy.
Milczarek M
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32640718
[TBL] [Abstract][Full Text] [Related]
20. The Emerging Role of Senotherapy in Cancer: A Comprehensive Review.
Malayaperumal S; Marotta F; Kumar MM; Somasundaram I; Ayala A; Pinto MM; Banerjee A; Pathak S
Clin Pract; 2023 Jul; 13(4):838-852. PubMed ID: 37489425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
